Ossiam’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-376,260
Closed -$5.24M 452
2020
Q3
$5.24M Sell
376,260
-321,865
-46% -$3.84M 0.22% 78
2020
Q2
$7.4M Hold
698,125
0.47% 42
2020
Q1
$5.63M Hold
698,125
0.38% 57
2019
Q4
$5.67M Buy
698,125
+170,400
+32% +$1.35M 0.43% 55
2019
Q3
$4M Buy
527,725
+273,220
+107% +$2.03M 0.28% 69
2019
Q2
$1.91M Hold
254,505
0.15% 116
2019
Q1
$2.06M Hold
254,505
0.17% 107
2018
Q4
$1.92M Buy
+254,505
New +$1.79M 0.29% 89

Other funds holding RDY

Ossiam's RDY Position: Q4 2020 in Review

Ossiam sold out of Dr. Reddy's Laboratories (RDY) in Q4 2020, closing a stake of 376,260 shares — an estimated $5.24M sold.

Ossiam first reported a position in RDY in Q4 2018 and held it in 8 quarters. The position peaked at $7.4M in Q2 2020. 174 funds tracked by Wall St. Rank hold RDY as of Q4 2020.

  • Ossiam reported no remaining Dr. Reddy's Laboratories position as of Q4 2020 after selling out during the quarter.
  • Ossiam sold 376,260 Dr. Reddy's Laboratories shares in Q4 2020, an estimated $5.24M.
  • Ossiam first reported a position in Dr. Reddy's Laboratories in Q4 2018 and held it in 8 quarters.
  • Ossiam's Dr. Reddy's Laboratories position peaked at $7.4M in Q2 2020.
  • 174 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2020.

Based on Ossiam's 13F filing for Q4 2020, filed 12 Feb 2021.